Presentations & Publications

Safety and Immunogenicity of a Personalized Neoantigen-Listeria Vaccine in Cancer Patients

Effects of ADXS-PSA With or Without Pembrolizumab on Survival and Antigen Spreading in Metastatic, Castration-Resistant Prostate Cancer Patients (Results from KEYNOTE-046)

AACR2019-keynote-046-adxs-psa-plus-pembrolizumab-metastatic-castration-resistant-prostate-cancer

AACR2019-adxs-neo-safety-and-immunogenicity-of-a-personalized-neoantigen

KEYNOTE-046 AACR 2019 Abstract

ADXS-NEO AACR 2019 Abstract

Presentation

KEYNOTE-046: ADXS-PSA Plus Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

ASCO 2018

Presentation

Targeting shared hotspot cancer mutations with a Listeria monocytogenes immunotherapy induce potent anti-tumor immunity

AACR 2018

Publication

Neoantigens that fail to elicit measurable T cell responses following peptide immunization can control tumor growth when delivered using a Listeria-based immunotherapy platform

AACR 2018

Presentation

Targeting frameshift mutations with a Listeria monocytogenes immunotherapy drives neoantigen-specific anti-tumor immunity in the MC38 and CT26 mouse tumor models

AACR 2018

Presentation

Targeting of CCR8 induces antitumor activity as a monotherapy that is further enhanced in combination with a Listeria-based immunotherapy

2018 Keystone Symposia on Cancer Immunotherapies: Combinations, March 25, 2018

Presentation

Combination TIGIT blockade with Listeria-based immunotherapy enhances antigen-specific antitumor immunity

2018 Keystone Symposia on Cancer Immunotherapies: Combinations, March 25, 2018

Presentation

Agonism of the CD137 co-stimulatory pathway synergizes with the Listeria monocytogenes-based immunotherapy, axalimogene filolisbac, to promote durable tumor regression in a murine HPV+ tumor model

2018 Keystone Symposia on Cancer Immunotherapies: Combinations, March 25, 2018

Publication

Immunotherapy: A New Strategy for the Treatment of Cervical Cancer

Interview with Dr. Christian Marth and Dr. Sharad Ghamande

Publication

Tolerability of ADXS11-001 Lm-LLO Listeria Based Immunotherapy With Mitomycin, Fluorouracil and Radiation for Anal Cancer

International Journal of Radiation Oncology, January 2018